|
HS Code |
536330 |
| Chemical Name | 4-Hydroxyquinazoline |
| Cas Number | 491-36-1 |
| Molecular Formula | C8H6N2O |
| Molecular Weight | 146.15 g/mol |
| Appearance | White to off-white powder |
| Melting Point | 300-305°C |
| Boiling Point | Unavailable |
| Solubility In Water | Slightly soluble |
| Density | Unavailable |
| Pubchem Cid | 68005 |
| Inchi Key | XLONQHVFJUBKLM-UHFFFAOYSA-N |
| Smiles | C1=CC=C2C(=C1)C(=NC=N2)O |
| Storage Conditions | Store at room temperature, in a dry place |
| Pka | Approx. 6.3 |
| Synonyms | 4-Quinazolinol |
As an accredited 4-Hydroxyquinazoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 4-Hydroxyquinazoline, 25g: Supplied in a sealed amber glass bottle with tamper-evident cap, labeled with hazard and product information. |
| Shipping | 4-Hydroxyquinazoline is shipped in tightly sealed containers to prevent contamination and moisture ingress. It is packed according to applicable chemical regulations, typically in glass or high-density polyethylene bottles, cushioned with packing material. Containers are clearly labeled with hazard warnings, and shipping follows standard safety protocols for laboratory chemicals. |
| Storage | 4-Hydroxyquinazoline should be stored in a tightly sealed container, protected from light and moisture. Keep the chemical in a cool, dry, and well-ventilated area, away from sources of heat and incompatible substances such as strong oxidizers. Clearly label the storage container and keep it in a designated chemical storage cabinet, following all relevant safety and regulatory guidelines. |
Applications of 4-Hydroxyquinazoline in Industrial Manufacturing4-Hydroxyquinazoline serves as a key intermediate in several sectors, supporting specialized synthesis and end-product innovation. As a manufacturer, we support downstream users with material consistency, defined impurity profiles, and technical guidance throughout the integration process. 1. Pharmaceutical API Intermediate SynthesisPharmaceutical companies deploy this compound in the synthesis of various quinazoline-based antibiotics, anticancer agents, and antihypertensive APIs. The material enters as a building block in ring formation, followed by functionalization tailored to the target molecule. Downstream formulations undergo rigorous validation under pharmacopeial controls. The compound’s purity and trace-metal content receive close attention to avoid cross-contamination, and documentation is kept ready for regulatory and batch release audits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Crop Protection Active Ingredient ManufacturingAgrochemical producers use 4-hydroxyquinazoline to synthesize herbicidal and fungicidal actives, leveraging its ring system as a core moiety. Customized processes adjust for substitution patterns, solubility, and environmental degradation kinetics. Analytical release includes both active potency and residue profiling. We provide full traceability and batch homogeneity data to meet both internal QC and external audit requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Dye and Pigment SynthesisThe pigment and dye manufacturing sector employs this compound as a precursor in the creation of high-performance colorants. The material’s heterocyclic structure imparts unique shades and improves lightfastness in pigment molecules. Manufacturers must monitor batch-to-batch color strength and impurity levels to meet industry acceptance tests. We assure shipment of consistent lots with defined colorimetric properties, supported by spectral and solubility certificates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Heterocyclic Polymer AdditivesManufacturers of specialty polymers and coatings adopt 4-hydroxyquinazoline as a monomeric intermediate to boost UV resistance and provide antioxidative properties. Precise dosing prevents color drift and supports compatibility with acrylate, polyurethane, and epoxy matrices. Process integration requires dry handling and micro-batch blending to secure uniform distribution. Resultant additives pass stability and compatibility evaluations required for advanced coatings and engineering plastics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Chemical Synthesis for Veterinary MedicineVeterinary API manufacturers use 4-hydroxyquinazoline to construct heterocyclic cores in antiparasitic and antibiotic ingredients for livestock treatment. Material selection focuses on impurity control, avoiding carryover of residual solvents or toxic by-products. Downstream partners require transparent COA and traceability reports for regulatory compliance, including import clearance in target markets. Documentation supports DMF and veterinary dossier submissions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
6. Research-Grade Intermediate for Analytical ReagentsProducers of analytical reagents and diagnostic kits employ this chemical for synthesis of chromogenic substrates and coupling agents in trace analyte detection. The material’s stability allows direct batch synthesis under controlled atmospheres, while high purity limits false positives in sensitive assays. End-users demand batch certificates containing residual solvent, impurity, and moisture content benchmarks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Hydroxyquinazoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 4-Hydroxyquinazoline gives us an inside view into both the science and the surprisingly practical demands of modern research and industry. The journey to create a fine-tuned batch isn’t about simply following scientific formulas or lining up numbers to match a spec sheet—it’s about working face-to-face with the unexpected grind of batch-to-batch consistency and understanding why someone working on the other side of the globe values this molecule in so many ways.
As a core intermediate, 4-Hydroxyquinazoline sits at an important crossroad between straightforward building blocks and advanced specialty compounds. The structure, a quinazoline ring with a hydroxy group at the fourth position, might appear basic to the untrained eye. But anyone with experience in heterocyclic chemistry recognizes the subtle advantages: increased reactivity, higher selectivity in modification, and, above all, versatility. Our model centers on purity and process stability, two sides of manufacturing that need constant attention with every lot we ship. Each batch filters through multiple analytical checkpoints, most notably HPLC and NMR, where our chemists track not just purity above 99%, but the minor impurities that can make or break pharmaceutical and agrochemical applications.
Customers commonly ask about the differences between our 4-Hydroxyquinazoline and similar compounds: say, 2-Hydroxyquinazoline or unsubstituted quinazoline. Positioning of the hydroxy group has a decisive effect on downstream synthesis, particularly nucleophilic substitution or condensation reactions. Placement at the fourth position creates alternate reaction sites, opening a larger window for subsequent derivatization and allowing tighter control over final product performance. Compared to its positional isomers or unsubstituted forms, this enables chemists to achieve higher yields and more predictable reactivity, especially in the context of pharmaceutical work or ligand design for advanced materials.
We constantly adjust our product grades based on direct customer input, not just theoretical purity targets. The standard specification usually sets a minimum purity of 99.0%, confirmed by HPLC, since trace-level impurities can matter enormously in downstream reactions. Moisture sits below 0.5%, and heavy metal residues fall far below most pharmacopoeia cutoffs, because we know assays for these traces multiply further down supply chains. The crystalline white powder yields predictable solubility in hot water and moderate polarity solvents, easing handling for custom synthesis.
What often gets overlooked in industry brochures is the effort behind texture and appearance: we listen to feedback on how the fine particulate interacts with different mixing and dosing equipment. We have seen firsthand how a poorly controlled crystallization can create bridging in feed augers or out-of-spec dissolution curves, especially on scale-up. Once, a small change in the cooling profile left us with slightly larger crystals that clogged a customer’s dosing line—there’s nothing theoretical about that kind of learning, it rewires the whole process.
4-Hydroxyquinazoline carries its greatest value as a key intermediate. In pharmaceuticals, it unlocks complex scaffolds that underpin kinase inhibitors, antibacterials and other heteroaromatic drug leads. Our clients use it in multi-step syntheses, often to prepare derivatives like N-alkyl or N-acyl analogues. The hydroxy group adds a reactive “handle” at the fourth position, which makes it ideal for condensation or etherification reactions. Beyond small-molecule drug development, researchers working with us drive new custom libraries, exploring SAR work for uncharted bioactivities.
Outside pharma, agrochemical groups depend on reliable supplies for products ranging from fungicides to plant growth regulators. Many of these applications demand not just high chemical purity, but crystalline consistency, because uniform morphology supports better blending into wettable powders or concentrates. Specialty chemical users find new ground through functional material synthesis—organic electronics, optical brighteners, and corrosion inhibitors have all emerged as novel destinations for our 4-Hydroxyquinazoline.
Occasionally, we field unusual requests tied to academic explorations. One customer, working on new ligands for transition metal catalysis, found that subtle shifts in residual metal content from one supplier to the next had a direct effect on his catalyst’s efficiency. He called asking if we could screen batches for palladium at trace levels. This kind of real-world collaboration constantly teaches us how critical it is to exceed the black-and-white lines of a printed spec—what’s invisible to most customers becomes a visible difference in the lab.
We’re often asked what sets this product apart from its cousins in the quinazoline family. Many researchers consider simple quinazoline or 2-methylquinazoline as alternatives, but application always drives the decision. The hydroxy group at the fourth position brings new reaction routes, improving the efficiency and selectivity of further transformations. Compared to derivatives with halogen, amino, or methyl substitutions, 4-Hydroxyquinazoline often provides increased reactivity due to the electron-donating effect of the hydroxyl group. This means reactions such as alkylation, acylation or ring closure can often run to completion under milder conditions.
On the topic of solubility, we’ve heard repeated feedback that certain derivatives fail to dissolve consistently due to slight differences in crystal-lattice organization or impurity profiles. Our batches, produced with close attention to control of hydration and filtration, help ensure smooth solubility in the most commonly used polar and mid-polar solvents—customers using methanol, ethanol, and DMF have noted fewer filtration headaches. Other market variants, especially those with extra methyl, amino, or methoxy substitutions, don’t always provide this kind of solution without extra downstream work.
It’s also worth mentioning user experience. Powder morphology means something different to every chemist, from those working at the milligram scale to those running reactors by the kilogram. We routinely adjust our crystallization and drying to optimize this aspect. Several research chemists have told us our 4-Hydroxyquinazoline consistently disperses well in solid mixers and suspends predictably in solution. Not every competitor can claim that kind of reproducibility: even small deviations in bulk density or trace-water carryover will alter handling, especially when sensitive glassware or automated feeders come into play.
Manufacturing for strict environments, whether pharma, agrochemical, or academic research, pushes us into continual re-examination of both process controls and documentation. On the shop floor, the best results come from blending experience and flexibility. All aspects, from starting material selection and reactor charge rates to filtration and drying protocols, rely on seasoned operators watching for physical and chemical cues. Once, a sudden change in raw material supplier left us with an impurity fingerprint picked up only at the final analytical check; we worked alongside the supplier, tracked down root causes, and refined our procedure to block the contaminant pathway.
Analytical labs checking each batch have to bridge routine QC and investigative problem-solving. Our QC cycles test not just for purity by HPLC and NMR, but for water by Karl Fischer titration and trace metals by ICP-MS. Color often matters more than expected, especially when customers each have their own standards. One researcher commented that a faint cream tint caused by minuscule iron levels led to a failed reaction via an unexpected Fenton-like mechanism—details like these have driven us to tighten controls on every step.
Traceability influences every gram of material that leaves our hands. From raw material tracking to batch documentation and customer feedback, the end-to-end process must create a transparent record. Auditors and researchers both prefer not to get caught unprepared by a regulatory surprise or an unexpected impurity spike. We keep every record, from lot geneology to in-process notes, immediately accessible for customer review.
Production doesn’t just throw straightforward roadblocks; it’s an unpredictable landscape. Water content, for instance, affects solubility, stability, and further synthesis. We’ve installed in-line sensors and adopted slow-evaporation processes that trim the moisture profile down to consistently below 0.5%. Batches that once showed frustrating stickiness, particularly on rainy manufacturing days, now come out free-flowing and dry, thanks to incremental improvements and shared stories from downstream users.
Logistics create their own headaches. Fine powders often have a knack for finding every weakness in packaging. We developed custom double-layered bags that hold up under variable climates, with desiccant packs to catch stray humidity. More than once, feedback from customers dealing with tropical storage conditions helped us tweak storage instructions so users from the European winter to Asian monsoon seasons get consistently usable powder.
Waste reduction matters more than ever, given global attention on sustainable manufacturing and tighter regulatory frameworks. Our team revises solvent recovery loops and optimizes filtration stages, not only to meet compliance targets but to drive down cost and environmental footprint. We look for ways to selectively remove impurities, trim energy usage, and recover valuable byproducts—a practice that started as internal policy but now forms a crucial selling point for customers tracking green metrics for their own products.
Customers don’t just look for chemical consistency—they want predictability batch after batch, especially for projects that run on a timeline. We’ve partnered with companies developing new antimicrobials, kinase inhibitors, and anti-inflammatory agents, and every time, the requirement for clean, analytically-controlled intermediate means zero tolerance for surprise byproducts. Several have used our product to prepare libraries of N-substituted derivatives, building out structure-activity relationships for entirely new drug candidates.
We’ve also seen creative adaptation outside human health. One agricultural customer, frustrated by variable granulation during blending, found more consistent crop responses after switching to our tightly-controlled crystal fractions. Those details—ranging from minimum fines to narrow crystal distribution—have real-world consequences, altering not only process efficiency, but long-term performance in the field.
Manufacturing is not a static job; every batch of 4-Hydroxyquinazoline writes a new chapter. Customer expectations change regularly with advances in analytical standards and evolving regulatory targets. In recent years, we’ve seen increased demand for more detailed impurity profiling and lower detection thresholds—now, requests for extended heavy metal screening and full chromatogram scans accompany the majority of pharmaceutical-scale orders.
On the operational side, digital tools have allowed us to track process drift or outliers faster than ever before. Automated data capture from reactors, integration of real-time QC metrics, and closer ties to supply chain logistics ensure that details never slip through the cracks. These efforts only matter when they translate to actual benefits for researchers, process chemists, and QA teams on the receiving end—fewer headaches, tighter project cycles, and better outcomes. We’ve seen that in repeat partnerships and in the way customer input shapes incremental improvements.
The journey through the manufacturing and refinement of 4-Hydroxyquinazoline brings more than just technical growth. Customer-to-customer variation, the subtle ways in which a single impurity can upend a critical reaction, and the ongoing hunt for efficiency all drive our commitment to keep learning. Each experience reinforces that chemistry is not only science but a craft, honed by careful observation and responsive action.
We remain committed to pushing the boundaries for 4-Hydroxyquinazoline—whether that means cleaner chemistry, faster turnaround, or greater flexibility in order handling. Every user—from research lab to full-scale production facility—relies on our efforts to deliver not just a molecule, but a foundation for progress. Putting knowledge into practice, supported by experience and open communication, brings us closer to that goal with every batch.